These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis. Menter DG; Steinert BW; Sloane BF; Taylor JD; Honn KV Cancer Res; 1987 May; 47(9):2425-32. PubMed ID: 3552214 [TBL] [Abstract][Full Text] [Related]
30. Low molecular weight heparin suppresses lymphatic endothelial cell proliferation induced by vascular endothelial growth factor C in vitro. Cao G; Wu JX; Wu QH Chin Med J (Engl); 2009 Jul; 122(13):1570-4. PubMed ID: 19719950 [TBL] [Abstract][Full Text] [Related]
31. A laboratory method for parallel determination of platelet aggregation and thrombin generation. Köstenberger M; Gallistl S; Cvirn G; Muntean W Clin Lab; 2004; 50(1-2):41-8. PubMed ID: 15000219 [TBL] [Abstract][Full Text] [Related]
32. [Anticoagulants and platelet aggregation inhibitors in urology]. Verdy E Prog Urol; 1997 Apr; 7(2):326-32. PubMed ID: 9264780 [TBL] [Abstract][Full Text] [Related]
33. Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture. Borrelli V; Sterpetti AV; Coluccia P; Randone B; Cavallaro A; Santoro D'Angelo L; Cucina A J Surg Res; 2001 Oct; 100(2):154-60. PubMed ID: 11592785 [TBL] [Abstract][Full Text] [Related]
34. Mast cell-derived heparin proteoglycans as a model for a local antithrombotic. Lassila R; Jouppila A Semin Thromb Hemost; 2014 Nov; 40(8):837-44. PubMed ID: 25393636 [TBL] [Abstract][Full Text] [Related]